Here at Get Your Boom! Back we love sharing with you the true stories of progress, to uplift and energise you. Together, let’s celebrate every day and live our best lives now and tomorrow.
We believe in changing the world in a way that’s positive for people and planet. This is verified, real, good news you are unlikely to have heard about, originally shared by FutureLoop, FutureCrunch, Peter Diamandis, Future Farming, Optimising Business, and other verified, accurate sources - brought to you here by Get Your Boom! Back.
The future’s bright and it’s the best time to be alive in human history. Here’s to living your best life.
That's exciting news! Rapid and accurate testing is essential in controlling the spread of respiratory infections such as influenza and Covid-19. The use of AI technology to analyze samples and identify different types of viruses can be a significant breakthrough in disease control and management.
The ability to differentiate between different viruses with one test is a remarkable advancement. Current tests take much longer to perform and require different testing methods for each virus type, which can be time-consuming and challenging for healthcare providers. The Oxford in UK researchers' approach has the potential to simplify and streamline the testing process, reducing the burden on healthcare workers and improving patient outcomes.
However, it's important to note that the new test will need to undergo further validation and testing before it can be widely used in clinical settings. It will also need to be assessed for its accuracy and reliability in real-world situations. Nonetheless, the development of such technology is a promising step towards more efficient and effective management of respiratory infections.
Source: Warp News
That is incredible news! Gene therapy has been a promising field for treating genetic diseases, and it's great to hear that it has been successful in treating MLD, which previously had no cure. The fact that this breakthrough was made possible through a collaboration between the NHS and Orchard Therapeutics is a testament to the power of partnerships between healthcare providers and pharmaceutical companies.
Libmeldy's success in treating MLD is an important milestone for gene therapy and will hopefully pave the way for further breakthroughs in treating other genetic diseases. It's a remarkable achievement that could potentially transform the lives of countless people and families affected by MLD.
It is great to hear that gene therapy has been successful in treating a young girl with MLD and that her condition has significantly improved. This breakthrough offers hope for many others suffering from this condition. Gene therapy involves replacing the defective gene responsible for the disease with a healthy version, delivered to the patient's body via a harmless virus.
It is encouraging that the NHS has announced that it will be offering the treatment to other eligible MLD patients, making it the first time that gene therapy has been made available on the NHS for this specific condition. This is a significant step forward for gene therapy and could pave the way for other gene therapies to be made more widely available to patients in need.
It is important to note that gene therapy is still a relatively new and evolving field, and more research is needed to fully understand its potential and limitations. However, this success story highlights the promise of gene therapy and the positive impact it can have on patients' lives. It's important to note that this breakthrough is still in the early stages, and more research is needed to fully understand the long-term effects of this treatment. Nonetheless, this news is undoubtedly a cause for celebration and hope for those affected by MLD and their loved ones.
Source: Warp News
To raise your spirits and encourage increased action for good, here at Get Your Boom! Back we’re focused on sharing the latest, fact-based, truthful information with you.
Here's to you Living Your Best Life